The crucial role of ANGPTL4 in governing plasma lipid levels in mice and humans has made ANGPTL4 an attractive therapeutic target for correcting dyslipidemia and associated cardiovascular disorders. This evidence concerns the gene ANGPTL4 and cardiovascular disorder.